Published in Pain on October 27, 2006
Systematic review of incidence and complications of herpes zoster: towards a global perspective. BMJ Open (2014) 1.81
Predictors of pain intensity and persistence in a prospective Italian cohort of patients with herpes zoster: relevance of smoking, trauma and antiviral therapy. BMC Med (2010) 1.15
Herpes Zoster and Postherpetic Neuralgia: Practical Consideration for Prevention and Treatment. Korean J Pain (2015) 0.96
Lost but making progress--Where will new analgesic drugs come from? Sci Transl Med (2014) 0.95
Postherpetic neuralgia: from preclinical models to the clinic. Neurotherapeutics (2009) 0.86
Post-herpetic neuralgia. Int J Gen Med (2012) 0.82
Epidemiology of Postherpetic Neuralgia in Korea: An Electronic Population Health Insurance System Based Study. Medicine (Baltimore) (2016) 0.79
One-year follow-up of patients with long-lasting post-herpetic neuralgia. BMC Infect Dis (2014) 0.79
Cost-effectiveness analysis of a vaccination program for the prevention of herpes zoster and post-herpetic neuralgia in adults aged 50 and over in Germany. Hum Vaccin Immunother (2015) 0.78
Acupuncture for the treatment of severe acute pain in herpes zoster: results of a nested, open-label, randomized trial in the VZV Pain Study. BMC Complement Altern Med (2011) 0.77
Inadequate evidence for a revised definition of postherpetic neuralgia (PHN). Pain (2007) 0.76
Postherpetic neuralgia #272. J Palliat Med (2013) 0.75
Local and systemic cytokine expression in patients with postherpetic neuralgia. PLoS One (2014) 0.75
Effects of pregabalin on acute herpetic pain and postherpetic neuralgia incidence. Wien Klin Wochenschr (2010) 0.75
The ACTTION-APS-AAPM Pain Taxonomy (AAAPT) Multidimensional Approach to Classifying Acute Pain Conditions. Pain Med (2017) 0.75
A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N Engl J Med (2005) 17.06
The short-form McGill Pain Questionnaire. Pain (1987) 14.40
Psychological stress and susceptibility to the common cold. N Engl J Med (1991) 6.84
The West Haven-Yale Multidimensional Pain Inventory (WHYMPI). Pain (1985) 6.48
Gabapentin for the treatment of postherpetic neuralgia: a randomized controlled trial. JAMA (1998) 5.16
The outcome of patients with herpes zoster. AMA Arch Derm (1957) 4.68
Postherpetic neuralgia--pathogenesis, treatment, and prevention. N Engl J Med (1996) 4.36
Oral opioid therapy for chronic peripheral and central neuropathic pain. N Engl J Med (2003) 3.82
Prevalence of postherpetic neuralgia after a first episode of herpes zoster: prospective study with long term follow up. BMJ (2000) 3.40
Opioids versus antidepressants in postherpetic neuralgia: a randomized, placebo-controlled trial. Neurology (2002) 3.21
Postherpetic neuralgia. J R Coll Gen Pract (1975) 2.57
Valaciclovir compared with acyclovir for improved therapy for herpes zoster in immunocompetent adults. Antimicrob Agents Chemother (1995) 2.16
Development of a measure of the burden of pain due to herpes zoster and postherpetic neuralgia for prevention trials: adaptation of the brief pain inventory. J Pain (2004) 2.15
Coping with chronic pain: a critical review of the literature. Pain (1991) 2.00
Analgesic therapy in postherpetic neuralgia: a quantitative systematic review. PLoS Med (2005) 1.96
Lack of effect of acyclovir on postherpetic neuralgia. BMJ (1989) 1.88
Risk factors for postherpetic neuralgia in patients with herpes zoster. Neurology (2004) 1.84
Risk factors for postherpetic neuralgia. Arch Intern Med (1997) 1.79
Herpes zoster and quality of life: a self-limited disease with severe impact. Neurology (1995) 1.73
Pain and its persistence in herpes zoster. Pain (1996) 1.68
The burden of Herpes Zoster: a prospective population based study. Vaccine (2005) 1.61
Phase specific analysis of herpes zoster associated pain data: a new statistical approach. Stat Med (2001) 1.60
Active and passive coping strategies in chronic pain patients. Pain (1996) 1.22
A high-risk method for studying psychosocial antecedents of chronic pain: the prospective investigation of herpes zoster. J Abnorm Psychol (1992) 1.15
Rash severity in herpes zoster: correlates and relationship to postherpetic neuralgia. J Am Acad Dermatol (2002) 1.12
Zoster-associated chronic pain: an overview of clinical trials with acyclovir. Scand J Infect Dis Suppl (1991) 1.07
Zoster-associated pain and neural dysfunction. Pain (2001) 1.02
Clinical applications for change-point analysis of herpes zoster pain. J Pain Symptom Manage (2002) 1.02
Pain coping strategies play a role in the persistence of pain in post-herpetic neuralgia. Pain (2003) 1.01
Proposed classification of herpes zoster pain. Lancet (1994) 0.99
Somatosensory findings in postherpetic neuralgia. J Neurol Neurosurg Psychiatry (1990) 0.97
The identification of risk factors associated with persistent pain following herpes zoster. J Infect Dis (1998) 0.95
Herpes zoster--predicting and minimizing the impact of post-herpetic neuralgia. J Antimicrob Chemother (2001) 0.95
The prognosis with postherpetic neuralgia. Pain (1991) 0.94
Allodynia and pinprick hypesthesia in acute herpes zoster, and the development of postherpetic neuralgia. J Pain Symptom Manage (2000) 0.91
Complex regional pain syndrome-like symptoms during herpes zoster. Pain (2004) 0.90
An application of the fear avoidance model to three chronic pain problems. Behav Res Ther (1992) 0.85
How should we measure pain in herpes zoster? Neurology (1995) 0.85
Topical aspirin in chloroform and the relief of pain due to herpes zoster and postherpetic neuralgia. Arch Neurol (1993) 0.85
How should zoster trials be conducted? J Antimicrob Chemother (1995) 0.83
Patients' experiences of herpes zoster and postherpetic neuralgia. J Adv Nurs (1995) 0.82
Pain and patienthood. Clin J Pain (1997) 0.79
Understanding pain in herpes zoster: an essential for optimizing treatment. J Infect Dis (2002) 0.78
Prospective epidemiologic study of painful and neurologic sequelae induced by herpes zoster in patients treated early with oral acyclovir. Neurology (1995) 0.78
Recommendations for the management of herpes zoster. Clin Infect Dis (2007) 4.33
Advances in neuropathic pain: diagnosis, mechanisms, and treatment recommendations. Arch Neurol (2003) 3.80
Opioid pharmacotherapy for chronic non-cancer pain in the United States: a research guideline for developing an evidence-base. J Pain (2010) 2.90
Pregabalin for the treatment of fibromyalgia syndrome: results of a randomized, double-blind, placebo-controlled trial. Arthritis Rheum (2005) 2.71
Abuse liability measures for use in analgesic clinical trials in patients with pain: IMMPACT recommendations. Pain (2013) 2.58
Informed Consent. N Engl J Med (2017) 2.56
A single dose of gabapentin reduces acute pain and allodynia in patients with herpes zoster. Neurology (2005) 2.00
Randomized control trial of topical clonidine for treatment of painful diabetic neuropathy. Pain (2012) 1.94
Considerations for improving assay sensitivity in chronic pain clinical trials: IMMPACT recommendations. Pain (2012) 1.88
Natural history of herpes zoster: late follow-up of 3.9 years (n=43) and 7.7 years (n=10). Pain (2013) 1.46
Does pain change the brain? Neurology (2005) 1.38
Pregabalin for postherpetic neuralgia: placebo-controlled trial of fixed and flexible dosing regimens on allodynia and time to onset of pain relief. J Pain (2008) 1.32
Gabapentin suppresses cutaneous hyperalgesia following heat-capsaicin sensitization. Anesthesiology (2002) 1.26
Placebo response in neuropathic pain trials. Pain (2008) 1.05
The lidocaine patch 5% effectively treats all neuropathic pain qualities: results of a randomized, double-blind, vehicle-controlled, 3-week efficacy study with use of the neuropathic pain scale. Clin J Pain (2002) 1.00
Relief of post-herpetic neuralgia by surgical removal of painful skin. Pain (2002) 0.99
A roadmap for academic health centers to establish good laboratory practice-compliant infrastructure. Acad Med (2012) 0.97
Natural history of cutaneous innervation following herpes zoster. Pain (2010) 0.97
The trafficking protein GABARAP binds to and enhances plasma membrane expression and function of the angiotensin II type 1 receptor. Circ Res (2008) 0.97
The Asp40 mu-opioid receptor allele does not predict naltrexone treatment efficacy in heavy drinkers. J Clin Psychopharmacol (2007) 0.97
Core outcome measures for opioid abuse liability laboratory assessment studies in humans: IMMPACT recommendations. Pain (2012) 0.95
Evidence-based clinical trial design for chronic pain pharmacotherapy: a blueprint for ACTION. Pain (2010) 0.95
Healthy volunteers can be phenotyped using cutaneous sensitization pain models. PLoS One (2013) 0.95
Gender differences in pain and secondary hyperalgesia after heat/capsaicin sensitization in healthy volunteers. J Pain (2006) 0.95
Assay sensitivity and study features in neuropathic pain trials: an ACTTION meta-analysis. Neurology (2013) 0.90
Complex regional pain syndrome-like symptoms during herpes zoster. Pain (2004) 0.90
Placebo-controlled comparison of a morphine/dextromethorphan combination with morphine on experimental pain and hyperalgesia in healthy volunteers. J Pain (2006) 0.89
Measurement of membrane-bound human heme oxygenase-1 activity using a chemically defined assay system. Drug Metab Dispos (2009) 0.88
A randomized study of the effect of oral lamotrigine and hydromorphone on pain and hyperalgesia following heat/capsaicin sensitization. J Pain (2003) 0.87
Adverse event assessment, analysis, and reporting in recent published analgesic clinical trials: ACTTION systematic review and recommendations. Pain (2013) 0.87
Naltrexone aversion and treatment efficacy are greatest in humans and rats that actively consume high levels of alcohol. Neurobiol Dis (2008) 0.85
Effect of a single dose of pregabalin on herpes zoster pain. Trials (2011) 0.85
Changes in morphine analgesia and side effects during daily subcutaneous administration in healthy volunteers. Pain (2007) 0.85
Does naloxone reinstate secondary hyperalgesia in humans after resolution of a burn injury? A placebo-controlled, double-blind, randomized, cross-over study. PLoS One (2013) 0.84
Natural history of sensory function after herpes zoster. Pain (2010) 0.83
Constitutive mutants of the GM-CSF receptor reveal multiple pathways leading to myeloid cell survival, proliferation, and granulocyte-macrophage differentiation. Blood (2003) 0.82
The case for publishing 'negative' clinical trials. Pain (2009) 0.81
Adherence to CONSORT harms-reporting recommendations in publications of recent analgesic clinical trials: an ACTTION systematic review. Pain (2012) 0.81
A snapshot and scorecard for analgesic clinical trials for chronic pain: the RReACT database. Pain (2012) 0.80
Discrepancies between registered and published primary outcome specifications in analgesic trials: ACTTION systematic review and recommendations. Pain (2013) 0.79
Relief of post-herpetic neuralgia by surgical removal of painful skin: 5 years later. Pain (2007) 0.78
Quantitative sensory testing scaled up for multicenter clinical research networks: a promising start. Pain (2006) 0.78
Map positions of third chromosomal female sterile and lethal mutations of Drosophila melanogaster. Genome (2004) 0.77
Pain's policy on the spinal administration of drugs. Pain (2010) 0.76
The Potential Role of Sensory Testing, Skin Biopsy, and Functional Brain Imaging as Biomarkers in Chronic Pain Clinical Trials: IMMPACT Considerations. J Pain (2017) 0.75
How to reduce the incidence of neuropathic pain: sentinel node biopsy for diagnosis of metastatic malignant melanoma. Pain (2011) 0.75
Double-Blind, Placebo-Controlled Pilot Study on the Use of Platelet-Rich Plasma in Women With Female Androgenetic Alopecia. Dermatol Surg (2016) 0.75
A second case of intrauterine growth retardation and primary hypospadias associated with a trisomy 22 placenta but with biparental inheritance of chromosome 22 in the fetus. Prenat Diagn (2002) 0.75
How should treatment results from clinical practice be reported? Pain (2008) 0.75
Early introduction of peanuts. JAAPA (2017) 0.75